Eosinophil-Derived Neurotoxin Is an Asthma Biomarker Linked to Wheezing Severity in Preschool Children
International Archives of Allergy and Immunology · 2025-09-29 · 187 (8) · 791-800
DOI: 10.1159/000548237 ↗Abstract
Introduction: Novel biomarkers are needed for understanding the clinical characteristics of children with acute wheeze (AW) and for optimizing management strategies. This study investigated serum eosinophil-derived neurotoxin (EDN) and blood eosinophil count (B-Eos) in Japanese preschool children with current asthma (CA) and/or AW. Methods: Two cohorts of Japanese children under 6 years of age were screened for allergy and asthma symptoms using the ISAAC questionnaire and tested for EDN, B-Eos, and specific IgE. Cohort 1 included 16 children with CA, 45 with other allergies (OA), e.g., eczema or rhinitis, and 34 healthy controls (HC). Optimal cut-offs (receiver operating characteristic analysis) for EDN and B-Eos were determined for CA vs. HC. Cohort 2 included 87 children with AW grouped according to symptom severity, high or low EDN and B-Eos (using the optimal cut-offs), and followed up during recovery. Results: Children with CA or OA had higher EDN vs. HC (p < 0.01). B-Eos was higher in CA vs. HC (p < 0.05). The optimal cut-offs for EDN and B-Eos were 26.5 µg/L and 235 cells/µL, respectively. EDN was higher in wheezing children with severe vs. mild or moderate symptoms (p < 0.05). Conversely, B-Eos were higher in children with mild vs. moderate AW symptoms (p < 0.01). EDN decreased in children with high EDN between acute visit and recovery (p < 0.001). High EDN, and to a lesser extent high B-Eos, were associated with IgE sensitization. Conclusion: Serum EDN is a promising exploratory biomarker for CA and AW in preschool children associated with wheezing severity and recovery after treatment.
EUVIMED